News
Last week, Citron's Andrew Left announced a short position against Palantir, suggesting that the stock was "beyond overvalued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results